SG Americas Securities’s VanEck Pharmaceutical ETF PPH Stock Holding History

SG Americas Securities’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50,000	Closed	-$3.22M	–	3255
2018 Q3	$3.22M	Hold	50,000	–	–	0.02%	809
2018 Q2	$2.95M	Hold	50,000	–	–	0.03%	698
2018 Q1	$2.84M	Buy	50,000 +46,358	+1,273%	+$2.77M	0.02%	679
2017 Q4	$216K	Sell	3,642 -100,000	-96%	-$5.73M	﹤0.01%	2382
2017 Q3	$5.99M	Buy	103,642 +100,000	+2,746%	+$5.68M	0.05%	271
2017 Q2	$215K	Buy	+3,642	New	+$206K	﹤0.01%	2382
2016 Q4	–	Sell	-6,095	Closed	-$350K	–	3380
2016 Q3	$350K	Buy	+6,095	New	+$366K	﹤0.01%	2028
2016 Q1	–	Sell	-1,725	Closed	-$113K	–	3192
2015 Q4	$113K	Hold	1,725	–	–	﹤0.01%	2348
2015 Q3	$109K	Hold	1,725	–	–	﹤0.01%	1822
2015 Q2	$122K	Buy	+1,725	New	+$124K	﹤0.01%	2249
2015 Q1	–	Sell	-39,529	Closed	-$2.54M	–	2970
2014 Q4	$2.54M	Buy	39,529 +29,309	+287%	+$1.87M	0.01%	878
2014 Q3	$650K	Buy	10,220 +8,608	+534%	+$533K	﹤0.01%	1346
2014 Q2	$100K	Buy	+1,612	New	+$95.8K	﹤0.01%	2340

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

SG Americas Securities's PPH Position: Q4 2018 in Review

SG Americas Securities sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2018, closing a stake of 50,000 shares — an estimated $3.22M sold.

SG Americas Securities first reported a position in PPH in Q2 2014 and held it in 13 quarters. The position peaked at $5.99M in Q3 2017. 45 funds tracked by Wall St. Rank hold PPH as of Q4 2018.

SG Americas Securities reported no remaining VanEck Pharmaceutical ETF position as of Q4 2018 after selling out during the quarter.
SG Americas Securities sold 50,000 VanEck Pharmaceutical ETF shares in Q4 2018, an estimated $3.22M.
SG Americas Securities first reported a position in VanEck Pharmaceutical ETF in Q2 2014 and held it in 13 quarters.
SG Americas Securities's VanEck Pharmaceutical ETF position peaked at $5.99M in Q3 2017.
45 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2018.

Based on SG Americas Securities's 13F filing for Q4 2018, filed 1 Feb 2019.